JP2004500037A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004500037A5 JP2004500037A5 JP2001521746A JP2001521746A JP2004500037A5 JP 2004500037 A5 JP2004500037 A5 JP 2004500037A5 JP 2001521746 A JP2001521746 A JP 2001521746A JP 2001521746 A JP2001521746 A JP 2001521746A JP 2004500037 A5 JP2004500037 A5 JP 2004500037A5
- Authority
- JP
- Japan
- Prior art keywords
- fgf
- polypeptide
- seq
- nucleic acid
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1999/020594 WO2000015666A2 (en) | 1998-09-10 | 1999-09-08 | Compositions and methods for the treatment of tumors |
| PCT/US1999/021090 WO2000015796A2 (en) | 1998-09-16 | 1999-09-15 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PCT/US1999/030999 WO2001005836A1 (en) | 1999-07-20 | 1999-12-20 | Polypeptidic compositions and methods for the treatment of tumors |
| PCT/US2000/004414 WO2001004311A1 (en) | 1999-07-07 | 2000-02-22 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PCT/US2000/006471 WO2001018210A1 (en) | 1999-09-08 | 2000-03-09 | Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004500037A JP2004500037A (ja) | 2004-01-08 |
| JP2004500037A5 true JP2004500037A5 (enExample) | 2007-05-10 |
Family
ID=27485920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001521746A Withdrawn JP2004500037A (ja) | 1999-09-08 | 2000-03-09 | 繊維芽細胞成長因子−１９（ｆｇｆ−１９）核酸及びポリペプチド並びに肥満の治療のための利用の方法 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1214409B1 (enExample) |
| JP (1) | JP2004500037A (enExample) |
| CN (1) | CN1560249A (enExample) |
| CA (1) | CA2384089A1 (enExample) |
| DE (1) | DE60028054T2 (enExample) |
| ES (1) | ES2264929T3 (enExample) |
| WO (1) | WO2001018210A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6716626B1 (en) | 1999-11-18 | 2004-04-06 | Chiron Corporation | Human FGF-21 nucleic acids |
| EP2163626A1 (en) * | 1999-11-18 | 2010-03-17 | Novartis Vaccines and Diagnostics, Inc. | Human FGF-21 gene and gene expression products |
| US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| JP4711600B2 (ja) | 2001-01-26 | 2011-06-29 | シェーリング コーポレイション | シトステロール血症の処置のための置換アゼチジノン化合物の使用 |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| SI1413331T1 (sl) | 2001-01-26 | 2008-02-29 | Schering Corp | Kombinacije fenofibrata peroksisomskega proliferator aktivirajocega receptorja (PPAR) z ezetimib zaviralcem absorpcije sterola za vaskularne indikacije |
| US7456184B2 (en) | 2003-05-01 | 2008-11-25 | Palatin Technologies Inc. | Melanocortin receptor-specific compounds |
| US7354923B2 (en) | 2001-08-10 | 2008-04-08 | Palatin Technologies, Inc. | Piperazine melanocortin-specific compounds |
| AU2002331064B2 (en) | 2001-08-10 | 2007-08-23 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| US7132415B2 (en) | 2001-09-21 | 2006-11-07 | Schering Corporation | Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| JP2005530687A (ja) * | 2002-01-31 | 2005-10-13 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | Ｆｇｆｒアゴニスト |
| US20050119206A1 (en) * | 2002-03-14 | 2005-06-02 | Develogen Aktiengesellschaft Fuerentwicklungsbolog | Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| AU2003243400B2 (en) | 2002-06-07 | 2009-10-29 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| AU2003274715A1 (en) * | 2002-06-10 | 2003-12-22 | Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung | L(2)44 dea, wunen-2, grapes, cg2221, cg1172, rutabaga, cg11940, facl involved in the regulation of energy homeostasis |
| EP2267117A3 (en) * | 2002-06-27 | 2011-07-13 | Verva Pharmaceuticals Pty Ltd | Differentiation modulating agents and uses therefor |
| WO2004026228A2 (en) * | 2002-09-18 | 2004-04-01 | Eli Lilly And Company | Method for reducing morbidity and mortality in critically ill patients |
| CA2504878A1 (en) | 2002-11-06 | 2004-05-27 | Schering Corporation | Cholesterol absorption inhibitors for the treatment of demyelination |
| ATE545428T1 (de) * | 2002-12-16 | 2012-03-15 | Develogen Ag | Pik4cb involviert in der regulierung des energiestoffwechsels |
| US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| CN1756755A (zh) | 2003-03-07 | 2006-04-05 | 先灵公司 | 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途 |
| CN100439361C (zh) | 2003-03-07 | 2008-12-03 | 先灵公司 | 取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途 |
| JP4589919B2 (ja) | 2003-03-07 | 2010-12-01 | シェーリング コーポレイション | 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用 |
| SI1680140T1 (sl) * | 2003-10-16 | 2011-08-31 | Imclone Llc | Inhibitorji receptorja-1 za fibroblastni rastni faktor in metode za zdravljenje z le-temi |
| CA2637988A1 (en) | 2006-02-10 | 2007-11-29 | Genentech, Inc. | Anti-fgf19 antibodies and methods using same |
| CA2693852C (en) | 2007-08-03 | 2016-11-29 | Genentech, Inc. | Humanized anti-fgf19 antagonists and methods using same |
| MX2010003606A (es) | 2007-10-01 | 2010-07-02 | Isis Pharmaceuticals Inc | Modulacion antisentido de la expresion del receptor del factor de crecimiento fibroblastico 4. |
| CA2839437A1 (en) | 2011-06-16 | 2012-12-20 | Isis Pharmaceuticals, Inc. | Antisense modulation of fibroblast growth factor receptor 4 expression |
| TWI728373B (zh) | 2013-12-23 | 2021-05-21 | 美商建南德克公司 | 抗體及使用方法 |
| CN113105561B (zh) * | 2021-04-30 | 2021-12-03 | 江南大学 | 一种双靶点融合蛋白的制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999014327A2 (en) * | 1997-09-17 | 1999-03-25 | Genentech, Inc. | Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer |
| JP2001516580A (ja) * | 1997-09-17 | 2001-10-02 | ジェネンテック・インコーポレーテッド | 分泌性の、および膜貫通性のポリぺプチド、およびそれをコードする核酸 |
| KR100506786B1 (ko) * | 1997-11-25 | 2005-08-08 | 제넨테크, 인크. | 섬유아세포 성장인자-19 |
-
2000
- 2000-03-09 ES ES00917878T patent/ES2264929T3/es not_active Expired - Lifetime
- 2000-03-09 EP EP00917878A patent/EP1214409B1/en not_active Expired - Lifetime
- 2000-03-09 CA CA002384089A patent/CA2384089A1/en not_active Abandoned
- 2000-03-09 WO PCT/US2000/006471 patent/WO2001018210A1/en not_active Ceased
- 2000-03-09 DE DE60028054T patent/DE60028054T2/de not_active Expired - Lifetime
- 2000-03-09 JP JP2001521746A patent/JP2004500037A/ja not_active Withdrawn
- 2000-03-09 CN CNA2004100465359A patent/CN1560249A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004500037A5 (enExample) | ||
| AU776457B2 (en) | Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as NGF-antagonist molecules | |
| KR100543730B1 (ko) | 종양 괴사 인자 관련 리간드 | |
| WO1998055620A1 (en) | Ntn-2 member of tnf ligand family | |
| WO1998055621A1 (en) | Ntn-2 member of tnf ligand family | |
| BG65519B1 (bg) | Белтъци, свързващи интерлевкин-18, тяхното получаване и приложение | |
| CA2195955A1 (en) | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof | |
| CN1142188A (zh) | 人生长激素 | |
| DE69530944T2 (de) | Keratinozyten-wachstumsfaktor 2 | |
| EP1019502A2 (en) | Human orphan receptor ntr-1 | |
| US5658783A (en) | Mammalian methadone-specific opioid receptor gene and uses | |
| JPH10511936A (ja) | ヒトソマトスタチン様受容体 | |
| JP2005528080A5 (enExample) | ||
| CA2262412A1 (en) | Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof | |
| US6297027B1 (en) | Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof | |
| AU753400C (en) | Orphan receptors | |
| JP4307708B2 (ja) | エストロゲン受容体 | |
| AU764484B2 (en) | Orphan cytokine receptor | |
| AU2004212622C1 (en) | A Tumor Necrosis Factor Related Ligand | |
| JP2002537812A5 (enExample) | ||
| MXPA99001134A (en) | Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof | |
| AU2007201600A8 (en) | Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof | |
| AU2003257868A1 (en) | Porcine Leptin Protein, Nucleic Acid Sequences Coding Therefor and Uses Thereof |